Pulegone

Chemical Properties

Pulegone (p-menth-8-en-3-one) is a monocyclic monoterpene ketone belonging to the menthane family of compounds, which includes menthol, menthone, carvone, and piperitone. The ketone carbonyl group at carbon-3 of the cyclohexane ring gives pulegone its distinctive reactivity profile and distinguishes it from the overwhelming majority of cannabis terpenes, which are hydrocarbons or alcohol terpenoids. Pulegone is biosynthetically upstream in the menthol pathway — it is converted to (+)-isomenthone and then to menthol through successive enzymatic reductions. Learn more about terpene chemistry fundamentals.

Property	Value
IUPAC name	(R)-(+)-p-Menth-8(20)-en-3-one / (4R)-4-methyl-1-(propan-2-ylidene)cyclohexan-2-one
Molecular formula	C10H16O
Molecular weight	152.23 g/mol
Boiling point	224°C (435°F)
Aroma profile	Intense mint, peppermint, camphor, herbaceous, slightly woody
Typical cannabis concentration range	0.001–0.05% (often below detection threshold; rarely >0.10%)
Solubility	Very low water solubility; high lipid solubility; miscible with ethanol and organic solvents
Functional group	Ketone (enone subtype — α,β-unsaturated carbonyl)
EFSA status	Restricted as food flavoring (2014) — genotoxicity concerns at high cumulative dietary intake
FDA status	GRAS revoked for high-level food flavoring use; naturally occurring trace levels not restricted

Biosynthesis: How Pulegone Is Produced

In mint plants (Mentha spp.), pulegone sits at a central junction of the menthol biosynthetic pathway. The pathway begins with the MEP (methylerythritol phosphate) route in plastids, which generates geranyl pyrophosphate (GPP, C10). The monoterpene synthase limonene synthase converts GPP to (+)-limonene, which is then hydroxylated by a cytochrome P450 enzyme (limonene-3-hydroxylase) to yield (+)-trans-isopiperitenol. A series of oxidation and reduction reactions — catalyzed by isopiperitenol dehydrogenase, isopiperitenone reductase, and isopulegone isomerase — eventually yields (+)-pulegone. Subsequent reduction by pulegone reductase converts pulegone to (+)-isomenthone, and further reductions produce (–)-menthol.

In cannabis, pulegone biosynthesis is not well characterized. Cannabis does not encode the full mint menthol pathway, and pulegone in cannabis likely arises as a low-level shunt product or trace metabolite from a related monoterpene pathway rather than from dedicated enzymatic synthesis. This explains why concentrations are so much lower in cannabis (micrograms per gram) than in mint plants (hundreds of milligrams per gram of essential oil). The specific terpene synthase or P450 responsible for trace pulegone production in cannabis has not been identified in published literature.

Mechanism of Action

Acetylcholinesterase (AChE) inhibition: Pulegone’s most pharmacologically notable activity is inhibition of acetylcholinesterase, the enzyme that hydrolyzes the neurotransmitter acetylcholine (ACh) into choline and acetate at synaptic junctions throughout the central and peripheral nervous system. By slowing ACh breakdown, AChE inhibitors prolong and amplify cholinergic neurotransmission — enhancing signal strength at muscarinic and nicotinic ACh receptors. Cholinergic pathways are central to memory consolidation (especially in the hippocampus), attention regulation, and arousal state maintenance.

This is precisely the mechanism exploited by the most widely prescribed Alzheimer’s disease medications: donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl). All three are AChE inhibitors approved for slowing cognitive decline in Alzheimer’s dementia. The research by Amaeze et al. (2014) documented pulegone’s AChE inhibitory capacity in vitro, with IC₅₀ values in a pharmacologically relevant range. Whether cannabis-delivered microgram quantities of pulegone contribute meaningfully to AChE inhibition in human subjects is unknown and would require specific pharmacokinetic modeling and clinical investigation.

TRPM8 receptor interaction: As a member of the mint terpene family, pulegone may interact with TRPM8, the thermosensitive TRP channel responsible for the sensation of cold and menthol-induced cooling. TRPM8 is expressed in sensory neurons, the bladder, and prostate tissue. Whether pulegone is a TRPM8 agonist, partial agonist, or modulator at physiologically relevant concentrations has not been definitively established, but the structural similarity to established TRPM8 ligands (menthol, icilin) makes this a plausible target.

Hepatotoxic metabolic pathway (high-dose only): At high doses — as seen in pennyroyal oil poisoning — pulegone undergoes hepatic biotransformation to reactive electrophilic intermediates. The primary toxic pathway involves cytochrome P450-mediated oxidation to pulegone epoxide and then to the highly reactive menthofuran, which depletes hepatic glutathione and generates reactive oxygen species, leading to centrilobular hepatic necrosis. This pathway is well-characterized in animal models and human poisoning case reports. At the microgram quantities delivered by cannabis, this metabolic pathway is not activated to any clinically meaningful degree.

Medical Evidence Summary

Effect / Application	Study / Source	Model Type	Dose	Outcome	Evidence Quality
AChE inhibition (memory)	Amaeze et al., 2014 (Pharm Biol)	In vitro enzyme inhibition assay; Nigerian folk medicine research context	IC50 ~18–35 µg/mL range	Significant AChE inhibition; comparable to physostigmine in assay conditions; context: traditional cognitive medicine	Early (in vitro)
Sedation / CNS depression	Matos et al., 1996 (Planta Med)	Mouse model, pentobarbital sleep potentiation; open field	100–400 mg/kg oral	Dose-dependent CNS depression; prolonged sleep time; reduced locomotor activity; no anxiolysis at low dose	Moderate (animal)
Hepatotoxicity (high-dose)	Gordon et al., 1987 (Biochem Pharmacol)	Rat model, pure pulegone compound	150–400 mg/kg i.p.	Hepatic glutathione depletion, menthofuran formation, centrilobular necrosis; dose-dependent toxicity	Strong (animal) — irrelevant to cannabis doses
EFSA Genotoxicity Review	EFSA ANS Panel, 2014 (EFSA Journal)	Regulatory review, Ames test + in vivo clastogenicity data	Chronic dietary exposure modeling	Genotoxic potential identified; margin of exposure (MoE) insufficient for unrestricted food flavoring use; restriction issued	Strong (regulatory)
Antimicrobial (food safety)	Mimica-Dukic et al., 2003 (Phytomedicine)	In vitro MIC broth dilution	MIC 0.5–4.0 mg/mL	Active against Listeria monocytogenes and Salmonella spp.; moderate efficacy vs. gram-negative organisms	Moderate (in vitro)
Anti-proliferative	Aeschbach et al., 2007 (Food Chem Toxicol)	In vitro, various cancer cell lines	10–100 µM	Cytostatic activity in some cell lines; concentration-dependent; mechanism uncharacterized	Early (in vitro)
Anti-inflammatory	de Sousa et al., 2006 (J Ethnopharmacol)	Rat carrageenan paw edema	50 mg/kg oral	Moderate reduction in edema; prostaglandin pathway modulation proposed; effect smaller than reference NSAIDs	Low–Moderate (animal)

Cannabis Strains Where Pulegone Has Been Detected

Pulegone is so rare in cannabis that many standard terpene panels do not include it, and analytical labs with detection limits above 0.01% will simply report it as not detected. The strains below have had pulegone reported on third-party lab results with sufficient frequency to be considered characteristic detections. Always check current COA data. Browse the full strain library.

Strain	Type	Pulegone Detection Range	Dominant Terpenes	Profile Notes
Bubba Kush	Indica-dominant	Trace (0.001–0.04%)	myrcene, caryophyllene, Limonene	Earthy, coffee-hash aroma; pulegone adds subtle herbal note in some phenotypes
Blue Cheese	Indica-dominant	Trace (0.002–0.05%)	Myrcene, Caryophyllene, Linalool	Complex earthy-cheese profile; pulegone rarely detected but recorded in select COAs
Trainwreck	Hybrid (Sativa-leaning)	Trace (0.002–0.04%)	Terpinolene, Myrcene, Ocimene	Minty-herbal undertones in some phenotypes correlate with pulegone presence
Peppermint Kush	Indica-dominant	Trace (0.005–0.08%)	Myrcene, Caryophyllene, Linalool	Named for minty aroma; pulegone is a likely contributor to the cooling herbal note
OG Kush (select phenotypes)	Hybrid	Trace (0.001–0.03%)	Myrcene, Limonene, Caryophyllene	Inconsistent detection across batches; not a defining terpene for this cultivar
Headband	Hybrid	Trace (0.001–0.02%)	Myrcene, Caryophyllene, Limonene	Complex multi-terpene profile; pulegone in some batch COAs

Entourage Effect: Synergy Potential

Pulegone’s entourage synergy potential is primarily theoretical given its trace concentrations in cannabis. The AChE inhibition mechanism is the most pharmacologically interesting basis for synergy discussion. The most compelling potential interaction is with alpha-pinene, which is also documented as an AChE inhibitor. Full terpene synergy context in our terpene guide.

Partner Compound	Potential Combined Effect	Mechanistic Basis	Evidence Level
Alpha-Pinene	Stacked AChE inhibition — memory and focus support	Alpha-pinene is independently documented as an AChE inhibitor (Perry et al., 2000); additive inhibitory effect theoretically plausible; both present in some complex cultivar profiles	Theoretical — mechanistically coherent but no co-administration data
CBD	Neuroprotective and memory support combination	CBD’s neuroprotective mechanisms (BDNF upregulation, neuroinflammation reduction) + pulegone AChE inhibition (cholinergic support); complementary cognitive pharmacology	Theoretical — no co-administration study; mechanistically plausible
Linalool	Enhanced sedation and anxiolysis	Both have CNS depressant properties; linalool modulates GABA-A receptors; pulegone potentiates pentobarbital sleep in animal models; combined sedation mechanistically plausible via separate pathways	Theoretical — both compounds individually studied; no combined data
Myrcene	Additive sedation, possible entourage analgesic	Myrcene is strongly sedative via GABA pathway; pulegone’s CNS depressant effect at any relevant dose adds potential synergy; both in indica-dominant profiles	Plausible — individually documented sedative mechanisms

Non-Cannabis Natural Sources of Pulegone

Plant	Part	Approximate Concentration
Mentha pulegium (pennyroyal)	Aerial parts essential oil	50–80% of EO — primary natural source; medicinal use dangerous due to hepatotoxicity at these concentrations
Mentha piperita (peppermint)	Leaf essential oil	1–10% (varies by chemotype); significant in trace-pulegone chemotypes
Mentha spicata (spearmint)	Leaf essential oil	Trace to 3% — minor mint-pathway product
Nepeta cataria (catnip)	Aerial parts essential oil	Trace amounts alongside nepetalactone; minor component
Rosmarinus officinalis (rosemary)	Leaf essential oil	Trace (some chemotypes); very minor component
Cannabis (Cannabis sativa L.)	Trichome-bearing flower	0.001–0.05% of dry weight — one of the rarest detectable terpenes

Extraction, Industrial & Commercial Uses

Pulegone is commercially produced almost exclusively from pennyroyal essential oil via steam distillation of Mentha pulegium aerial parts. Pennyroyal has historically been cultivated in Mediterranean Europe, North Africa, and the Middle East, and its essential oil was used as a flea repellent, insecticide, and abortifacient in folk medicine — the latter use being extremely dangerous due to hepatotoxicity. Commercial pulegone is now primarily obtained for analytical reference standards, flavor research, and limited specialty fragrance applications.

In food science, pulegone has been used as a flavoring agent to impart peppermint character to confectionery, gum, and beverages, though the EFSA 2014 restriction and subsequent regulatory actions in EU member states have significantly reduced its permitted application levels. The FDA’s GRAS status for pulegone at high use levels has similarly been questioned, leading most large manufacturers to replace it with menthol, L-carvone, or other mint compounds with cleaner safety profiles.

In fragrance, pulegone contributes minty-herbaceous top notes to some perfumery compositions, though its use is minor compared to other mint compounds. Cosmetic use is limited and subject to concentration restrictions in some regulatory frameworks due to sensitization potential at high concentrations. Cannabis-derived pulegone is not commercially relevant in isolation given its extremely low concentrations in flower.

Safety & Toxicology

The safety profile of pulegone is uniquely two-tiered: at trace cannabis concentrations it presents no established risk, but it becomes genuinely hazardous at the high doses found in concentrated pennyroyal preparations. This distinction is essential for evidence-based assessment.

At cannabis concentrations (micrograms/session): No meaningful toxicological risk. The metabolic pathway generating hepatotoxic intermediates (menthofuran, pulegone epoxide) requires substantial hepatic P450 processing of milligram quantities. Consumer cannabis sessions deliver an estimated 1–50 micrograms of pulegone — well below any toxicologically relevant threshold. The EFSA restriction on food flavoring applies to scenarios of regular, substantial dietary intake from artificially pulegone-enriched foods, not to botanical trace amounts.

At pennyroyal oil doses (milligrams to grams): Documented severe hepatotoxicity in multiple human poisoning case reports. Symptoms include nausea, vomiting, abdominal pain, and elevated liver enzymes progressing to fulminant hepatic failure at very high doses. Several fatalities have been attributed to pennyroyal oil ingestion, particularly in attempted abortions. This risk is entirely irrelevant to cannabis consumption.

Genotoxicity concern: The EFSA 2014 review identified genotoxic potential in Ames test assays and in vivo clastogenicity studies at high pulegone doses. The margin of exposure calculation was insufficient to support unrestricted food additive use. Again, this concern applies to scenarios of repeated substantial dietary intake, not to trace botanical quantities.

For cannabis consumers specifically: no special precautions regarding pulegone are warranted. It is one of hundreds of trace compounds in cannabis flower, present at levels that are toxicologically insignificant. The scientific documentation of its hazard at high doses is included here for complete accuracy, not because it represents a risk in the context of cannabis use.

Cannabis Terpene Science — Video

Frequently Asked Questions